Your session is about to expire
← Back to Search
Opioid
methadone group for Long QT Syndrome
Phase 4
Recruiting
Led By Glenn S Murphy, MD
Research Sponsored by NorthShore University HealthSystem
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
All patients presenting for elective surgical cases requiring general anesthesia and associated with moderate-to-severe postoperative pain will be eligible for enrollment.
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 30 minutes after post anesthesia care unit admission
Awards & highlights
Study Summary
This study is evaluating whether a drug called methadone may help reduce the risk of a potentially lethal heart rhythm problem in patients who have undergone surgery.
Eligible Conditions
- Long QT Syndrome
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 30 minutes after postanesthesia care unit admission
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~30 minutes after postanesthesia care unit admission
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
QT prolongation on the EKG 30 minutes after postanesthesia care unit admission
Secondary outcome measures
Level of pain on a 0-10 scale on the morning of postoperative day one
Level of pain on on a 0-10 scale 30 minutes after postanesthesia care unit admission
QT prolongation on the EKG on the morning of postoperative day one
Trial Design
2Treatment groups
Active Control
Placebo Group
Group I: methadone groupActive Control1 Intervention
Patients in this group will receive a syringe of methadone at the induction of anesthesia and a syringe of saline at the end of anesthesia.
Group II: hydromorphone groupPlacebo Group1 Intervention
Patients in this group will receive a syringe of saline at induction of anesthesia and a syringe of hydromorphone at the end of anesthesia
Find a Location
Who is running the clinical trial?
NorthShore University HealthSystemLead Sponsor
132 Previous Clinical Trials
737,720 Total Patients Enrolled
Glenn S Murphy, MDPrincipal InvestigatorNorthShore University HealthSystem
8 Previous Clinical Trials
1,010 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Share this study with friends
Copy Link
Messenger